Thomas Smart is the founder of Actym Therapeutics, Inc.. Actym Therapeutics, Inc. has raised $60M in total funding. Latest round: Series A.
Thomas E. Smart is the Chief Executive Officer of Actym Therapeutics, Inc., a biotechnology company focused on oncology trials and its STACT platform. He has held the CEO position at Actym since 2024. Smart is also the founder of Gravitas Therapeutics, Inc.
Full founder directory · Investor directory · Company funding database · Fundraising library